{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:25:07Z","timestamp":1793413507177,"version":"4.5.0"},"reference-count":104,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.jceh.2021.12.003","type":"journal-article","created":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T11:42:39Z","timestamp":1638963759000},"page":"937-947","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["Vaccination in Chronic Liver Disease: An Update"],"prefix":"10.1016","volume":"12","author":[{"given":"Joseph J.","family":"Alukal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haider A.","family":"Naqvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4374-4507","authenticated-orcid":false,"given":"Paul J.","family":"Thuluvath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2021.12.003_bib1","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1016\/j.cgh.2019.07.060","article-title":"Contemporary epidemiology of chronic liver disease and cirrhosis","volume":"18","author":"Moon","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2021.12.003_bib2","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/gutjnl-2019-318813","article-title":"Epidemiology of chronic liver diseases in the USA in the past three decades","volume":"69","author":"Younossi","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2021.12.003_bib3","unstructured":"https:\/\/ftp.cdc.gov\/pub\/Health_Statistics\/NCHS\/NHIS\/SHS\/2018_SHS_Table_A-4.pdf."},{"key":"10.1016\/j.jceh.2021.12.003_bib4","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1002\/hep.28677","article-title":"Prevalence of chronic liver disease and cirrhosis by underlying cause in understudied ethnic groups: the multiethnic cohort","volume":"64","author":"Setiawan","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.12.003_bib5","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.jhep.2014.08.010","article-title":"Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance","volume":"61","author":"Albillos","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.12.003_bib6","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3389\/fimmu.2019.00293","article-title":"Causes and consequences of innate immune dysfunction in cirrhosis [published correction appears in Front Immunol. 2019 Apr 09;10:818]","volume":"10","author":"Irvine","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jceh.2021.12.003_bib7","unstructured":"https:\/\/www.cdc.gov\/flu\/about\/burden\/index.html."},{"key":"10.1016\/j.jceh.2021.12.003_bib8","unstructured":"https:\/\/www.cdc.gov\/flu\/about\/viruses\/types.html."},{"key":"10.1016\/j.jceh.2021.12.003_bib9","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/cld.898","article-title":"Optimizing vaccination in adult patients with liver disease and liver transplantation","volume":"15","author":"Rhee","year":"2020","journal-title":"Clin Liver Dis (Hoboken)."},{"key":"10.1016\/j.jceh.2021.12.003_bib10","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.jhep.2018.11.015","article-title":"Influenza virus infection as precipitating event of acute-on-chronic liver failure","volume":"70","author":"Sch\u00fctte","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.12.003_bib11","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1001\/archinte.160.1.113","article-title":"Hepatic decompensation in patients with cirrhosis during infection with influenza A","volume":"160","author":"Duchini","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jceh.2021.12.003_bib12","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jceh.2018.04.006","article-title":"A\/H1N1\/09 influenza is associated with high mortality in liver cirrhosis","volume":"9","author":"Premkumar","year":"2019","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2021.12.003_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jmv.23454","article-title":"Clinical impact of A\/H1\/N1\/09 influenza in patients with cirrhosis: experience from a nosocomial cluster of infection","volume":"85","author":"Marzano","year":"2013","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.jceh.2021.12.003_bib14","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ijid.2020.04.013","article-title":"Clinical manifestations and risk factors for mortality of patients with severe influenza during the 2016-2018 season","volume":"95","author":"Liu","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jceh.2021.12.003_bib15","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1750-2659.2012.00424.x","article-title":"Immunogenicity of influenza A(H1N1)pdm09 vaccine and the associated factors on lowered immune response in patients with hepatitis C","volume":"7","author":"Ohfuji","year":"2013","journal-title":"Influenza Other Respir Viruses"},{"issue":"suppl 5","key":"10.1016\/j.jceh.2021.12.003_bib16","doi-asserted-by":"crossref","first-page":"B33","DOI":"10.1016\/S0264-410X(02)00510-8","article-title":"Immunogenicity and safety of an adjuvanted influenza vaccine in patients with decompensated cirrhosis","volume":"20","author":"Gaeta","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.jceh.2021.12.003_bib17","doi-asserted-by":"crossref","first-page":"e031070","DOI":"10.1136\/bmjopen-2019-031070","article-title":"Effectiveness of influenza vaccines in adults with chronic liver disease: a systematic review and meta-analysis","volume":"9","author":"H\u00e4rm\u00e4l\u00e4","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.jceh.2021.12.003_bib18","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.mayocpiqo.2020.06.007","article-title":"Quality of care in patients with cirrhosis: trends in recommended adult vaccination coverage","volume":"4","author":"Ahmmad","year":"2020","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"10.1016\/j.jceh.2021.12.003_bib19","series-title":"Influenza Immunisation Programme for England: GP Patient Groups - Data Collection Survey Season 2015 to 2016","year":"2016"},{"key":"10.1016\/j.jceh.2021.12.003_bib20","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1002\/jmv.26763","article-title":"Low influenza vaccination coverage in subjects with liver cirrhosis. An alert waiting for winter season 2020-2021 during the COVID-19 pandemic","volume":"93","author":"Stroffolini","year":"2021","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.jceh.2021.12.003_bib21","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.15585\/mmwr.mm6846a5","article-title":"Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged \u226565 Years: updated recommendations of the advisory committee on immunization practices","volume":"68","author":"Matanock","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jceh.2021.12.003_bib22","unstructured":"https:\/\/www.cdc.gov\/pneumococcal\/surveillance.html."},{"key":"10.1016\/j.jceh.2021.12.003_bib23","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1016\/j.vaccine.2016.07.003","article-title":"Risk of underlying chronic medical conditions for invasive pneumococcal disease in adults","volume":"34","author":"Baxter","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.jceh.2021.12.003_bib24","first-page":"1900","article-title":"Risk of hospitalization due to pneumococcal disease in adults in Spain. The CORIENNE study","volume":"12","author":"Gil-Prieto","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.jceh.2021.12.003_bib25","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1111\/j.1572-0241.2007.01286.x","article-title":"Bacterial infection-related morbidity and mortality in cirrhosis","volume":"102","author":"Christou","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"suppl 1","key":"10.1016\/j.jceh.2021.12.003_bib26","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0168-8278(12)60002-6","article-title":"Management of bacterial infections in cirrhosis","volume":"56","author":"Fern\u00e1ndez","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.12.003_bib27","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jhep.2014.03.021","article-title":"Epidemiology and outcomes of bloodstream infection in patients with cirrhosis","volume":"61","author":"Bartoletti","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.12.003_bib28","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/MD.0b013e318210504c","article-title":"Community-acquired pneumonia in patients with liver cirrhosis: clinical features, outcomes, and usefulness of severity scores","volume":"90","author":"Viasus","year":"2011","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jceh.2021.12.003_bib29","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/hep.1840080520","article-title":"A\u00a0prospective evaluation of bacteremic patients with chronic liver disease","volume":"8","author":"Barnes","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.12.003_bib30","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1097\/MCG.0000000000000964","article-title":"Bacteremia in patients with liver cirrhosis: prevalence and predictors of multidrug resistant organisms","volume":"52","author":"Addo Smith","year":"2018","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.jceh.2021.12.003_bib31","article-title":"Clinical features and outcomes of spontaneous bacterial peritonitis caused by Streptococcus pneumoniae: a matched case-control study","volume":"95","author":"Kim","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jceh.2021.12.003_bib32","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1086\/315245","article-title":"Pneumococcal vaccine response in cirrhosis and liver transplantation","volume":"181","author":"McCashland","year":"2000","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jceh.2021.12.003_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss7003a1","article-title":"Surveillance of vaccination coverage among adult populations -United States, 2018","volume":"70","author":"Lu","year":"2021","journal-title":"MMWR Surveill Summ"},{"key":"10.1016\/j.jceh.2021.12.003_bib34","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1007\/s10620-005-2873-5","article-title":"Immunization needs of chronic liver disease patients seen in primary care versus specialist settings","volume":"50","author":"Jacobs","year":"2005","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jceh.2021.12.003_bib35","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jhep.2020.09.024","article-title":"Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: an international registry study","volume":"74","author":"Marjot","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.12.003_bib36","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jhep.2020.07.040","article-title":"Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients","volume":"74","author":"Colmenero","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.12.003_bib37","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1053\/j.gastro.2020.09.033","article-title":"Clinical characteristics, hospitalization, and mortality rates of coronavirus disease 2019 among liver transplant patients in the United States: a multicenter research network study","volume":"160","author":"Mansoor","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2021.12.003_bib38","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1002\/hep.31574","article-title":"Liver injury in liver transplant recipients with coronavirus disease 2019 (COVID-19): U.S. Multicenter experience","volume":"72","author":"Rabiee","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.12.003_bib39","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S2468-1253(20)30271-5","article-title":"Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study","volume":"5","author":"Webb","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2021.12.003_bib40","doi-asserted-by":"crossref","first-page":"674","DOI":"10.15585\/mmwr.mm7018e1","article-title":"Effectiveness of Pfizer-BioNTech and Moderna vaccines against COVID-19 among hospitalized adults aged \u226565 years - United States, January-March 2021","volume":"70","author":"Tenforde","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jceh.2021.12.003_bib41","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2021.12.003_bib42","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2021.12.003_bib43","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.jhep.2021.08.008","article-title":"Analysis of antibody responses after COVID-19 vaccination in liver transplant recipients and those with chronic liver diseases","volume":"75","author":"Thuluvath","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.12.003_bib44","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/hep.31751","article-title":"American Association for the Study of Liver Diseases Expert Panel Consensus statement: vaccines to prevent coronavirus disease 2019 infection in patients with liver disease","volume":"74","author":"Fix","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.12.003_bib45","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.jhep.2021.01.032","article-title":"EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients","volume":"74","author":"Cornberg","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.12.003_bib46","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1001\/jama.2021.7489","article-title":"Antibody response to 2-dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients","volume":"325","author":"Boyarsky","year":"2021","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.jceh.2021.12.003_bib47","doi-asserted-by":"crossref","DOI":"10.1002\/lt.26273","article-title":"Antibody response to severe acute respiratory syndrome-coronavirus-2 messenger RNA vaccines in liver transplant recipients","author":"Strauss","year":"2021","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jceh.2021.12.003_bib48","article-title":"Effectiveness of SARS-Cov-2 vaccination in liver transplanted patients: the debate is open! [published online ahead of print, 2021 Aug 3]","author":"Guarino","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.12.003_bib49","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jhep.2021.04.020","article-title":"Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients","volume":"75","author":"Rabinowich","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.12.003_bib50","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.7326\/L21-0282","article-title":"Safety and immunogenicity of a third dose of SARS-CoV-2 vaccine in solid organ transplant recipients: a case series","volume":"174","author":"Werbel","year":"2021","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jceh.2021.12.003_bib51","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1056\/NEJMc2108861","article-title":"Three doses of an mRNA covid-19 vaccine in solid-organ transplant recipients","volume":"385","author":"Kamar","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2021.12.003_bib52","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1056\/NEJMc2111462","article-title":"Randomized trial of a third dose of mRNA-1273 vaccine in transplant recipients","volume":"385","author":"Hall","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2021.12.003_bib53","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0168-8278(98)80198-0","article-title":"Characteristics of patients with dual infection by hepatitis B and C viruses","volume":"28","author":"Zarski","year":"1998","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.12.003_bib54","first-page":"259","article-title":"Chronic hepatitis C virus infection with exposure to hepatitis B virus","volume":"30","author":"Ilan","year":"1994","journal-title":"Isr J Med Sci"},{"key":"10.1016\/j.jceh.2021.12.003_bib55","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1002\/1097-0142(19941101)74:9<2442::AID-CNCR2820740909>3.0.CO;2-#","article-title":"Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study","volume":"74","author":"Benvegn\u00f9","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.jceh.2021.12.003_bib56","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1053\/jhep.2000.19288","article-title":"Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C, and delta viruses in patients with chronic hepatitis","volume":"32","author":"Sagnelli","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.12.003_bib57","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1111\/j.1572-0241.2000.02337.x","article-title":"Impact of acute hepatitis B virus superinfection on chronic hepatitis C virus infection","volume":"95","author":"Liaw","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2021.12.003_bib58","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/0016-5085(93)90425-C","article-title":"Hepatitis C virus RNA and hepatitis B virus DNA in serum and liver of patients with fulminant hepatitis","volume":"104","author":"F\u00e9ray","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2021.12.003_bib59","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3109\/00365529109025042","article-title":"Chronic evolution of acute hepatitis B: the significance of simultaneous infections with hepatitis C and D","volume":"26","author":"Krogsgaard","year":"1991","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jceh.2021.12.003_bib60","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1053\/jhep.2002.36509","article-title":"HBV superinfection in hepatitis C virus chronic carriers, viral interaction, and clinical course","volume":"36","author":"Sagnelli","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.12.003_bib61","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/0264-410X(94)90283-6","article-title":"Infuence of smoking on immunological responses to hepatitis B vaccine","volume":"12","author":"Winter","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.jceh.2021.12.003_bib62","doi-asserted-by":"crossref","first-page":"9316","DOI":"10.1016\/j.vaccine.2011.10.011","article-title":"Evaluation of hepatitis B vaccine immunogenicity among older adults during an outbreak response in assisted living facilities","volume":"29","author":"Tohme","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.jceh.2021.12.003_bib63","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1080\/21645515.2016.1164362","article-title":"Prospective clinical trial of hepatitis B vaccination in adults with and without type-2 diabetes mellitus","volume":"12","author":"Van Der Meeren","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.jceh.2021.12.003_bib64","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1001\/jama.1985.03360220053027","article-title":"Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine","volume":"254","author":"Weber","year":"1985","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.jceh.2021.12.003_bib65","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/lt.500040208","article-title":"Is vaccination against hepatitis B infection indicated in patients waiting for or after orthotopic liver transplantation?","volume":"4","author":"Chalasani","year":"1998","journal-title":"Liver Transpl Surg"},{"key":"10.1016\/j.jceh.2021.12.003_bib66","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0002-9629(15)40643-3","article-title":"Vaccination against hepatitis B in patients with chronic liver disease awaiting liver transplantation","volume":"318","author":"Horlander","year":"1999","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.jceh.2021.12.003_bib67","doi-asserted-by":"crossref","first-page":"196704","DOI":"10.1155\/2013\/196704","article-title":"Safety and efficacy of hepatitis B vaccination in cirrhosis of liver","volume":"2013","author":"Roni","year":"2013","journal-title":"Adv Virol"},{"key":"10.1016\/j.jceh.2021.12.003_bib68","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.1942","article-title":"Response to hepatitis B vaccination in patients with liver cirrhosis","volume":"27","author":"Aggeletopoulou","year":"2017","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.jceh.2021.12.003_bib69","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.cgh.2018.08.047","article-title":"Efficacy of high-dose, rapid, hepatitis A and B vaccination schedules in patients with cirrhosis","volume":"17","author":"Wigg","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2021.12.003_bib70","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1007\/s10620-020-06437-6","article-title":"Two-dose hepatitis B vaccine (Heplisav-B) results in better seroconversion than three-dose vaccine (Engerix-B) in chronic liver disease","volume":"66","author":"Amjad","year":"2021","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jceh.2021.12.003_bib71","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jhep.2019.03.034","article-title":"Taormina Workshop on Occult HBV Infection Faculty Members. Update of the statements on biology and clinical impact of occult hepatitis B virus infection","volume":"71","author":"Raimondo","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.12.003_bib72","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1053\/j.gastro.2017.02.009","article-title":"Hepatitis B reactivation associated with immune suppressive and biological modifier therapies: current concepts, management strategies, and future directions","volume":"152","author":"Loomba","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2021.12.003_bib73","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.bbmt.2008.08.007","article-title":"HB vaccination in the prevention of viral reactivation in allogeneic hematopoietic stem cell transplantation recipients with previous HBV infection","volume":"14","author":"Onozawa","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jceh.2021.12.003_bib74","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1038\/s41409-020-0833-5","article-title":"A\u00a0prospective trial of vaccine to prevent hepatitis B virus reactivation after hematopoietic stem cell transplantation","volume":"55","author":"Nishikawa","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jceh.2021.12.003_bib75","first-page":"201","article-title":"Is hepatitis A more severe in patients with chronic hepatitis B and other chronic liver diseases?","volume":"90","author":"Keeffe","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2021.12.003_bib76","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1056\/NEJM199801293380503","article-title":"Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C","volume":"338","author":"Vento","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2021.12.003_bib77","series-title":"Viral Hepatitis and Liver Disease","first-page":"76","article-title":"Clinical spectrum and natural history of viral hepatitis in a 1988 Shanghai epidemic","author":"Yao","year":"1991"},{"key":"10.1016\/j.jceh.2021.12.003_bib78","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/BF03404264","article-title":"Fulminant hepatitis A in patients with chronic liver disease","volume":"91","author":"Lefilliatre","year":"2000","journal-title":"Can J Public Health"},{"key":"10.1016\/j.jceh.2021.12.003_bib79","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.jhep.2005.06.012","article-title":"An outbreak of hepatitis A virus infection with a high case-fatality rate among injecting drug users","volume":"43","author":"Spada","year":"2005","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.12.003_bib80","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1080\/21645515.2020.1832408","article-title":"Need for hepatitis A prevention in patients with chronic liver disease in the changing epidemiological setting of India","volume":"17","author":"Raju","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.jceh.2021.12.003_bib81","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/hep.510270336","article-title":"Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease","volume":"27","author":"Keeffe","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.12.003_bib82","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1016\/S0264-410X(99)00524-1","article-title":"Immunogenicity of a combined hepatitis A and B vaccine in healthy young adults","volume":"18","author":"Knoll","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.jceh.2021.12.003_bib83","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1053\/jhep.2001.25883","article-title":"Immunogenicity of hepatitis A vaccination in decompensated cirrhotic patients","volume":"34","author":"Arguedas","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.12.003_bib84","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/hep.24024","article-title":"Meeting vaccination quality measures for hepatitis A and B virus in patients with chronic hepatitis C infection","volume":"53","author":"Kramer","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.12.003_bib85","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1002\/hep.24510","article-title":"Changes in hepatitis A and B vaccination rates in adult patients with chronic liver diseases and diabetes in the US population","volume":"54","author":"Younossi","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.12.003_bib86","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1111\/liv.13164","article-title":"Vaccination against hepatitis A and B in patients with chronic liver disease and type 2 diabetes: has anything changed?","volume":"36","author":"Koenig","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2021.12.003_bib87","unstructured":"https:\/\/www.cdc.gov\/shingles\/hcp\/clinical-overview.html#epidemiology."},{"key":"10.1016\/j.jceh.2021.12.003_bib88","doi-asserted-by":"crossref","first-page":"e93443","DOI":"10.1371\/journal.pone.0093443","article-title":"No increased risk of herpes zoster found in cirrhotic patients: a nationwide population-based study in Taiwan","volume":"9","author":"Wu","year":"2014","journal-title":"PLos One"},{"key":"10.1016\/j.jceh.2021.12.003_bib89","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1002\/lt.20219","article-title":"Herpes zoster after liver transplantation: incidence, risk factors, and complications","volume":"10","author":"Herrero","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jceh.2021.12.003_bib90","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/tid.12425","article-title":"Incidence and risk factors for herpes zoster in patients undergoing liver transplantation","volume":"17","author":"Hamaguchi","year":"2015","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jceh.2021.12.003_bib91","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","article-title":"Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults","volume":"372","author":"Lal","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2021.12.003_bib92","doi-asserted-by":"crossref","first-page":"103","DOI":"10.15585\/mmwr.mm6703a5","article-title":"Recommendations of the advisory committee on immunization practices for use of herpes zoster vaccines","volume":"67","author":"Dooling","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jceh.2021.12.003_bib93","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/cid\/ciz177","article-title":"Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in chronically immunosuppressed adults following renal transplant: a phase 3, randomized clinical trial","volume":"70","author":"Vink","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jceh.2021.12.003_bib94","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1001\/jama.2019.9053","article-title":"Effect of recombinant zoster vaccine on incidence of herpes zoster after autologous stem cell transplantation: a randomized clinical trial","volume":"322","author":"Bastidas","year":"2019","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.jceh.2021.12.003_bib95","unstructured":"https:\/\/www.cdc.gov\/vaccines\/schedules\/hcp\/imz\/adult-conditions.html."},{"key":"10.1016\/j.jceh.2021.12.003_bib96","unstructured":"https:\/\/www.aasld.org\/sites\/default\/files\/2021-02\/AASLD-COVID19-VaccineDocument-February2021-FINAL.pdf."},{"key":"10.1016\/j.jceh.2021.12.003_bib97","doi-asserted-by":"crossref","first-page":"e13563","DOI":"10.1111\/ctr.13563","article-title":"On Behalf of the AST ID Community of Practice. Vaccination of solid organ transplant candidates and recipients: guidelines from the American society of transplantation infectious diseases community of practice","volume":"33","author":"Danziger-Isakov","year":"2019","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jceh.2021.12.003_bib98","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1016\/S0264-410X(99)00064-X","article-title":"Immunity to poliomyelitis, diphtheria and tetanus in pediatric patients before and after renal or liver transplantation","volume":"17","author":"Balloni","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.jceh.2021.12.003_bib99","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/00007890-199703270-00008","article-title":"Routine immunizations in adult renal transplant recipients","volume":"63","author":"Huzly","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2021.12.003_bib100","doi-asserted-by":"crossref","first-page":"e56974","DOI":"10.1371\/journal.pone.0056974","article-title":"Serologic vaccination response after solid organ transplantation: a systematic review","volume":"8","author":"Eckerle","year":"2013","journal-title":"PLos One"},{"key":"10.1016\/j.jceh.2021.12.003_bib101","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/cld.1123","article-title":"Live vaccines in pediatric liver transplant recipients: \u201cTo Give or Not to Give\u201d","volume":"18","author":"Kemme","year":"2021","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"10.1016\/j.jceh.2021.12.003_bib102","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/AOG.0000000000000581","article-title":"Vaccinations for pregnant women","volume":"125","author":"Swamy","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jceh.2021.12.003_bib104","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41390-019-0507-4","article-title":"Under-immunization of pediatric transplant recipients: a call to action for the pediatric community","volume":"87","author":"Feldman","year":"2020","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jceh.2021.12.003_bib105","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/petr.12765","article-title":"Studies of pediatric liver transplantation (SPLIT) research group. Immunization practices among pediatric transplant hepatologists","volume":"20","author":"Feldman","year":"2016","journal-title":"Pediatr Transplant"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688321005831?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688321005831?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:08:16Z","timestamp":1760854096000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688321005831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":104,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0973688321005831"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2021.12.003","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccination in Chronic Liver Disease: An Update","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2021.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}